Rangeley Capital »

Springworks Therapeutics shares owned by Rangeley Capital

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.1M 47k 44.13

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Sanctuary Advisors
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics